Compare UCAR & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCAR | YI |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Retail-Drug Stores and Proprietary Stores |
| Sector | Consumer Discretionary | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.5M | 30.8M |
| IPO Year | 2022 | 2018 |
| Metric | UCAR | YI |
|---|---|---|
| Price | $4.00 | $3.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.0K | 15.0K |
| Earning Date | 10-12-2026 | 09-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $36.96 |
| Revenue Next Year | $13.33 | $14.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.04 | $2.48 |
| 52 Week High | $8.99 | $11.17 |
| Indicator | UCAR | YI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.46 |
| Support Level | N/A | $2.58 |
| Resistance Level | N/A | $4.00 |
| Average True Range (ATR) | 0.00 | 0.25 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 0.00 |
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.